Wolverine Trading, LLC Seagen Inc. Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$191.51 - $216.16 $243,600 - $274,955	1,272 New	1,272 $269,000
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $498,939 - $591,611	-4,251 Reduced 63.5%	2,444 $314,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $905,632 - $1.21 Million	6,695 New	6,695 $909,000
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $11,721 - $15,469	98 Added 2.66%	3,782 $535,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $3,564 - $4,771	25 Added 0.68%	3,684 $579,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $55,697 - $66,399	391 Added 11.96%	3,659 $601,000
Q2 2021 Aug 06, 2021	SELL	$135.08 - $161.1 $569,227 - $678,875	-4,214 Reduced 56.32%	3,268 $518,000
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $839,223 - $1.16 Million	6,103 Added 442.57%	7,482 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $227,024 - $292,251	1,379 New	1,379 $253,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.